Supplementary Data. β-actin IL-13Rα2 65 kDa 42 kDa G26-H2 G26-V2 SnB19-pcDNA SnB19-asIL-13Rα2 Figure S1A.

Slides:



Advertisements
Similar presentations
P-4E-BP1/4E-BP1P-p70 S6K/p70 S6K ND cleaved PARP/PARPLC3II/LC3I Supplementary Figure 1 Relative levels A BC P-Akt/Akt.
Advertisements

Knight et al – Supplementary Table Supplemental Table 1: Cell line Densitometry AROSSIRT1 ARPE WI MCF10A HCT HCT116.
P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.
Supplementary Figure 1. DAXX S564A does not change Mdm2/p53 stability or p53 ‑ mediated gene expression. (A) U2OS cells stably transduced with pCDH-DAXX.
(+++) Normal breast ATM (++) IDC ATM Lymph node metastasis negative positive P-value A B X200 C Vector ATM - WT.
Condensed TUNEL + cells (%) WT RanBP9 Tg B The scale bar represents 50  m A CA1 TUNEL Wild TypeRanBP9 Tg P
(z=7) (z=7) (z=7) (z=7) MSMS/MS Ba 7702 Bc AH819 Bc Bc AH259 b y y b b 9 2+ b y 33.
A B C 3500x8900x 5600x14 000x 1500x5000x Supplementary Figure 1 TiO 2 Carbon black SWCNT.
94Q S Q S 19Q S W1W Q 19Q TAP eluate 94Q S-1 W2 W1 W2 S-1A. Verification of TAP by Western blot (anti-FLAG). S: supernatant of cell lysate.
Time (days) A % Overall Survival Time (days) % Overall Survival SUPPLEMENTAL FIGURE 1 Legend: MMTV-Cre, n = 71 R26(Pik3ca), n = 285 R26(Stat3), n = 46.
D Day 2Day 1Day 4Day 6 Day 1 Day 2 Day 4 Day 6 Biopsy Injury D0 D1 D2 D3 D4 D5 D6 Wound monitoring by endoscope & Intrarectal adminstration of LGG or HBSS.
min 30 min 45 min 60 min KDa Figure S1. SDS-PAGE of supernatant after incubation in digestion buffer. L. monocytogenes.
Figure S1 (Kim et al) Introduction into the Saccharomyces cerevisiae reporter strain AH109 (Trp-/Leu-/His-/Ade-) pGBKT7-hsRad21 human fetal kidney cDNA.
(hr) Cleaved Caspase-9 Caspase nM Paclitaxel MCF-7 Figure S1a.
SIRTs inhibitor: Sirtinol Supplementary Figure S3A Supplementary Figure S3 Sirtinol but not EX527 or PDF-170 significantly enhances ithe cytotoxic and.
Supplementary Table S1 Clinical exposure for palbociclib, fulvestrant and chemotherapeutic agents used in this study. Palbociclib (1)*Paclitaxel (2)*Doxorubicin.
7/ N 74W 72W Gradient Strength (au) Boundary Frequency (%) SeaWiFS Chl a (mg m -3 ) Ocean Sat Chl a (mg m.
SA-β-Gal positivity (%) Days after 6 Gy of IR exposure 3 Morphology SA-  -Gal 015 Supplementary Fig. S1 A B.
Figure1 HER2 SKBr3 PC3 A. SKBr3 cells Figure (µM) Penetratin control % of control (µM)
Constituent protein characteristics Constituent detected peptide characteristics Figure S1A.
Figure S1: kinetics of incubation time and temperature MFI Incubation time (min) B Room temperature +4°C D Room temperature +4°C Incubation time (min)
Supplementary Figure S1 a
Supplementary Fig. 1 *** Cell viability (%) HepG2 3 (hr) DU145 A549 17
Supplementary Figure 1. A B C MP-MRT-AN KP-MRT-NS KP-MRT-RY KP-MRT-YM
Figure 1. Screening and detection of lyszozyme-specific ligands during the consecutive rounds of panning (A) Schematic procedure for the panning of lysozyme.
Figure 1 C. LDH release D. Cell viability E. Cell proliferation
CO20 CO 40 CO 80   Figure S1a: HR-TEM images and quantitative particle size distribution analysis of (A-B) CO20 ; (C-D) CO40 ; and (E-F) CO80 gold NPs.
Supplementary Figure 1: Clinical parameters of the breast tumor samples used for the study. IDC = Invasive ductal carcinoma and ILC= Invasive Lobular.
Volume 78, Issue 8, Pages (October 2010)
Hiroki Ando, Sebastien Lemire, Diana P. Pires, Timothy K. Lu 
Angiogenesis Inhibitors
Supplementary Figure 1. Longitudinal study in a representative number of SLE patients one year before (t1), at the time (t2), and one year after renal.
Supplementary figures
Volume 98, Issue 1, Pages (July 1999)
Suppl.Figure 1 Transfected HEK293 cells -130kDa -100KDa Blot: -V5
Days after cell inoculation Days after cell inoculation
Days after cell inoculation Days after cell inoculation
Supplementary Figure 1 Non-migrating cells Migrating cells
Volume 10, Issue 6, Pages (December 2002)
Molecular Therapy - Nucleic Acids
Volume 137, Issue 6, Pages (June 2009)
Supplemental Figure 1A – I
Flavonoid DAPI Mitotracker
A B C D ID8 vector scr sh cx2 cx3 cx4 cx6 CX3CR1 β-tubulin * ID8
R 1.1 t' r'. ').. "'. I{III{II \I\I ' IIII t J I I f c t -
Bonnie N Dittel, IrenaŠtefanova, Ronald N Germain, Charles A Janeway 
AE1/AE3 Rabbit Normal IgG Supplementary Figure S1 White bar = 5 mm
Supplementary Figure S1
Volume 43, Issue 1, Pages e5 (October 2017)
Supplementary Figure 1. A
HeLa COS-7 Supplementary Figure S1 Coelho et al (2014) MM pSPL3 MM
Marina Cardó-Vila, Wadih Arap, Renata Pasqualini  Molecular Cell 
Table S1: Characteristics of the cancer patients
Volume 20, Issue 4, Pages (April 2011)
TNF-α Induces Two Distinct Caspase-8 Activation Pathways
Volume 43, Issue 1, Pages e5 (October 2017)
Supplementary Figure S4
Volume 11, Issue 1, Pages (January 2004)
Coupled Caspase and N-End Rule Ligase Activities Allow Recognition and Degradation of Pluripotency Factor LIN-28 during Non-Apoptotic Development  Benjamin.
Mutant Alanine Position
Volume 24, Issue 6, Pages (June 2016)
Johannes Hampl, Yueh-hsiu Chien, Mark M Davis  Immunity 
Supplementary Figure S3
C A B * * * * HCC1954 HCC1569 Supplementary-Figure S5 Tumor cells sc.
Effect of a Fusion Peptide by Covalent Conjugation of a Mitochondrial Cell-Penetrating Peptide and a Glutathione Analog Peptide  Carmine Pasquale Cerrato,
MW (kDa) 2 µg 0.5 µg Supplementary Figure S1. SDS-PAGE under reducing condition analysis (Coomassie brilliant blue staining) of.
Social Isolation Induces Rac1-Dependent Forgetting of Social Memory
Supplement Figure 1 Untreated Thermal IMDP CPLL Untreated Thermal IMDP
HLA-A*0201 restriction of SSX2-derived p stimulated CD8+ T-cells.
Fig. 1. Induction of microglial cell motility by OPNpt20
Presentation transcript:

Supplementary Data

β-actin IL-13Rα2 65 kDa 42 kDa G26-H2 G26-V2 SnB19-pcDNA SnB19-asIL-13Rα2 Figure S1A

Phage clones (pfu/ml) 10 9 Pep-1Pep-2Pep-3M13KE Figure S1B DTT (-) DTT (+) O.D. - A 405 nm

Concentration (µg/ml) Figure S1C IL-13R  2-Fc IgG-Fc BSA Pep-1-L Pep-1-DSC Pep-1-L (C/S) Control Pep-1-L Control Pep-1-DSC O.D. - A 405 nm

1 µg/ml5 µg/ml U-251 MG Pep-1-DSC Pep-1-L Figure S2 A

Pep-1-L B T98G cells Pep-1-DSC Figure S2 1 µg/ml5 µg/ml

Scrambled Pep-1-L U-251 MG cells C No peptide 1 µg/ml Figure S2 5 µg/ml

Figure S2 D

Figure S3A Strep- Cys5.5 Strep- Cys5.5 Strep- Cys min2 hr8 hr 24 hr72 hr Pep-1-DSC Ctrl. Pep-1-DSC SalinePep-1-DSC Ctrl. Pep-1-DSC SalinePep-1-DSC Ctrl. Pep-1-DSC Saline 48 hr Pep-1-DSC Ctrl p = * Total NIR Radiant efficiency (x 10 ) 10

Luciferin Figure S3B Pep-1-DSC Ctrl. Strep- Cy5.5 Saline hr

Figure S4 A B i.ii.iii. i.ii.iii.